Opus Genetics GAAP EPS of -$0.14 beats by $0.02, revenue of $0.75M misses by $1.82M — See source for full details.
$IRD
Price history, market instrument context, member research, and related headlines in one place.
IRD key statistics
NasdaqCMUSD
52-week range
$1.7045%$7.07
Latest session $4.08–$4.37Opus Genetics, Inc. (IRD) is a stock instrument quoted on NasdaqCM in USD. The most recently published price is $4.10, down $0.14 (3.30%) from the previous close of $4.24. It has traded between $4.08 and $4.37 in the latest session. Over the past year it has ranged from $1.70 to $7.07, leaving it around the middle of its 52-week range (45%). Reported volume for the session was 1.2M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Opus Genetics COO Joseph Schachle sells $13,653 in common stock — See source for full details.
Opus Genetics CEO George Magrath sells $27,925 in common stock — See source for full details.
Opus Genetics CFO Robert Gagnon sells $22,941 in company stock — See source for full details.
Loading $IRD research…